Scientific Literature Search

Open access

alpha-Synuclein and neuronal cell death.

Cookson MR.

Mol Neurodegener · 2009-02-04

DOI: 10.1186/1750-1326-4-9PMID: 19193223

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study.

Brighina L, Schneider NK, Lesnick TG, de Andrade M, Cunningham JM, Mrazek D, Rocca WA, Maraganore DM.

Parkinsonism Relat Disord · 2009-02-04

DOI: 10.1016/j.parkreldis.2008.11.011PMID: 19196539

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Evidence that alpha-synuclein does not inhibit phospholipase D.

Rappley I, Gitler AD, Selvy PE, LaVoie MJ, Levy BD, Brown HA, Lindquist S, Selkoe DJ.

Biochemistry · 2009-02-01

DOI: 10.1021/bi801871hPMID: 19146388

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease.

Rakovic A, Stiller B, Djarmati A, Flaquer A, Freudenberg J, Toliat MR, Linnebank M, Kostic V, Lohmann K, Paus S, Nürnberg P, Kubisch C, Klein C, Wüllner U, Ramirez A.

Mov Disord · 2009-02-01

DOI: 10.1002/mds.22399PMID: 19097176

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.

Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, Yue M, Lincoln S, Aasly JO, Haugarvoll K, Trojanowski JQ, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Gibson JM, Lynch T, Dickson DW, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Mov Disord · 2009-02-01

DOI: 10.1002/mds.22442PMID: 19133659

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Clinical and genetic description of a family with a high prevalence of autosomal dominant restless legs syndrome.

Young JE, Vilariño-Güell C, Lin SC, Wszolek ZK, Farrer MJ.

Mayo Clin Proc · 2009-02-01

DOI: 10.4065/84.2.134PMID: 19181647

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Alpha-synuclein pathology and Parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions.

Betts-Henderson J, Jaros E, Krishnan KJ, Perry RH, Reeve AK, Schaefer AM, Taylor RW, Turnbull DM.

Neuropathol Appl Neurobiol · 2009-02-01

DOI: 10.1111/j.1365-2990.2008.00981.xPMID: 19187065

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Evidence against a reliable staging system of alpha-synuclein pathology in Parkinson's disease.

Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK.

Neuropathol Appl Neurobiol · 2009-02-01

DOI: 10.1111/j.1365-2990.2008.00998.xPMID: 19187066

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein.

Liu J, Zhang JP, Shi M, Quinn T, Bradner J, Beyer R, Chen S, Zhang J.

J Neurosci · 2009-02-01

DOI: 10.1523/jneurosci.6202-08.2009PMID: 19193894

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.

Lu XH, Fleming SM, Meurers B, Ackerson LC, Mortazavi F, Lo V, Hernandez D, Sulzer D, Jackson GR, Maidment NT, Chesselet MF, Yang XW.

J Neurosci · 2009-02-01

DOI: 10.1523/jneurosci.5351-08.2009PMID: 19228951

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity.

Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, Hill KJ, Caldwell KA, Caldwell GA, Cooper AA, Rochet JC, Lindquist S.

Nat Genet · 2009-02-01

DOI: 10.1038/ng.300PMID: 19182805

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotype.

Pirkevi C, Lesage S, Condroyer C, Tomiyama H, Hattori N, Ertan S, Brice A, Başak AN.

Neurogenetics · 2009-01-27

DOI: 10.1007/s10048-009-0173-5PMID: 19172321

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

14.936 articles found

alpha-Synuclein and neuronal cell death.

Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study.

Evidence that alpha-synuclein does not inhibit phospholipase D.

Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease.

FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.

Clinical and genetic description of a family with a high prevalence of autosomal dominant restless legs syndrome.

Alpha-synuclein pathology and Parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions.

Evidence against a reliable staging system of alpha-synuclein pathology in Parkinson's disease.

Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein.

Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.

Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity.

A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotype.

Filters